Network-anchored functional genomics identifies intra-tumoral axes of vulnerability in pancreatic cancer (View Now | 50 mins)
Lineage Tracing to Dissect Functional Heterogeneity of Tumor Cells (View Now | 27 mins)
CRISPR/Cas9 screens to investigate mechanisms of Cancer Drug Resistance (View Now | 50 mins)
Critical role of ARID1A in determining the luminal identity and therapeutic response in estrogen receptor positive (ER+) breast cancer (View Now | 25 mins)
NGS technologies and RNA Expression profiling for Single-Cell Genetic Analysis (View Now | 27 mins)
Application of DriverMap™Target RNA-Sequencing in Drug Screening (View Now | 20 mins)
Efficient Tools to Enable Drug Target and Biomarker Discovery: An Introduction to Cellecta Technologies (View Now | 20 mins)
Customer Presentation: D2G Oncology – Quantitative and Multiplexedin vivoFunctional Cancer Genomics Using Barcoded CRISPR Libraries (View Now | 20 mins)
Assessment of Immune status and Biomarker Discovery using Blood Transcriptomics (View Now | 16 mins)
Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries (View Now | 55 mins)
Molecular Snapshot with DriverMap™ Targeted Expression Profiling Assay (View Now | 25 mins)
Oral Presentations
DriverMap™: Profiling the Tumor Microenvironment and Biomarkers with CancerNet™, April 2016, AACR Annual Meeting (PDF)
CRISPR and RNAi Loss-of-Function Genetic Screens, March 2016, MMTC (PowerPoint Slide Show)
For a list of the upcoming events we’re attending, please visit Cellecta’sEventspage.